The invention provides application of
nicotinamide ribose in preparation of drugs for increasing the number of primordial germ cells and prolonging the
growth cycle, and relates to the technical field of
cell biology. Animal experiments prove that the supplement of
nicotinamide ribose in the embryonic period can significantly increase the number of PGCs and prolong the post-birth
growth cycle, and the action mechanism comprises:
nicotinamide ribose promotes the proliferation of embryonic cells by up-regulating the NAD + level in PGCs, and enhances the expression of TFAP2C at the same time to maintain the undifferentiated state of cells and
delay the
meiosis initiation of female
embryo PGCs and the differentiation
initiation of male
embryo PGCs; in post-birth effect evaluation, the number of follicles in ovaries of the female child rats in the NR group is remarkably increased, the
fertility cycle is remarkably prolonged, the
fertility of filial generations is not affected, and nicotinamide ribose is prompted to effectively maintain reproductive reserve and enhance the
fertility by optimizing the development
time sequence of PGCs. The invention provides a
solid experimental foundation for the application of nicotinamide ribose in increasing the number of primordial germ cells and prolonging the
growth cycle, and has a wide application prospect.